The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57.
Albany International Corp.
AIN · the NYSE · USD · Market cap $1.9B · 5,700 employees
Albany International Corp., together with its subsidiaries, engages in the machine clothing and engineered composites businesses in the United States, Switzerland, France, Brazil, China, Mexico, Germany, and internationally.
PASS · Titan Ethical · score 70.0Price as of 17 Nov 2026Daily close, not a live quote
Screened 2026-11-17 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price65.72 USD at the 17 Nov 2026 close
- Our value readFair vs our fair value, as of 17 Nov 2026
- Our regime readMarkup, as of 16 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans to puts (put/call 1.33)
- Last reviewed17 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $63.90 to $86.93, base estimate $70.27 (screen dated 2026-11-17).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 1.33, read 2026-11-17
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Albany International Corp. holds its Markup at $65.72. Consolidating, no directional conviction, held for 9 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 9 days |
| Price at the screen | $65.72 |
| Valuation | 21.62 trailing · 20.79 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.16 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 27.19% | Below 33% | Interest-bearing debt is just 27.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 19.43% | Below 49% | Money owed to the company is 19.4% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.44% | Below 5% | Only 0.4% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Albany International clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when AIN's ethical verdict changes
Today AIN passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 17 Nov 2026: it trades at roughly a 6% discount to our $70.27 fair value, 33.70% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. A 6.5% discount to the base estimate.
Third-party analyst targets: 3 covering, consensus Hold. The average target sits +8% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $70.27, with a range of $63.90 to $86.93, dated to the 2026-11-17 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsMachine clothing firm priced far above fair value
Picture the endless belts that turn raw pulp into paper or reinforce aircraft parts. Albany International makes those critical components, yet the numbers show a business still posting losses and negative returns on equity while revenue edges up just 8 percent.
We pass because the shares sit 45 percent above our fair value with a forward multiple of 24 times and no economic moat visible. Analyst targets cluster around 61 dollars and the consensus is merely hold, so the market already sees limited upside.
Cyclical exposure in textiles and composites adds the usual earnings swings, and any recovery could easily disappoint if volumes stall. Analysis, not advice.
| Forward P/E | 20.8xcheap for a company growing this fast |
| Trailing P/E | 21.6xa premium valuation |
| EPS, trailing | 3.04 |
| EPS, forward | 3.16 |
| Revenue growth | +33.7%strong top-line growth |
| Profit margin | 6.7%thin but positive margins |
| Return on equity | 11.6%a modest return on shareholder capital |
| FCF yield | 3.89% |
| Dividend yield | 1.73% |
| Debt to equity | 0.54moderate, manageable leverage |
| Current ratio | 2.41comfortably covers its short-term bills |
| Beta | 1.16moves a little more than the market |
| Short interest, float | 0.04% |
| 52-week range | 41.15 - 77.00 |
| Market cap | $1.9B |
| Employees | 5,700 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeAIN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 13.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Is Albany International (AIN) Stock Outpacing Its Industrial Products Peers This Year? Yahoo Finance · 6d ago
- 3 Solid Stocks to Grab as Manufacturing Activity Hits 3-Month High Yahoo Finance · 13d ago
- Albany International Announces Participation at Upcoming Conferences Yahoo Finance · 14d ago
- How Earnings Beat At Albany International (AIN) Has Changed Its Investment Story Yahoo Finance · 18d ago
- What Albany International (AIN) Said on Its Q3 Earnings Call Yahoo Finance · 19d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-06 | Gil Cisneros | Democrat | sell | 1K–15K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 100K–250K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $61.17 | +10.2% | $0.28 | $1,107 | +10.7% |
| 2 months | $56.97 | +18.3% | $0.28 | $1,188 | +18.8% |
| 3 months | $54.14 | +24.5% | $0.56 | $1,255 | +25.5% |
| 6 months | $52.29 | +28.9% | $0.84 | $1,305 | +30.5% |
| 1 year | $67.23 | +0.3% | $1.11 | $1,019 | +1.9% |
| 2 years | $80.87 | -16.7% | $2.18 | $860 | -14.0% |
| 3 years | $86.90 | -22.4% | $3.21 | $813 | -18.7% |
| 5 years | $83.18 | -19.0% | $5.00 | $871 | -12.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever AIN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.